The Effects of Heparin, Protamine, and Heparinase 1 on Platelets in vitro Using Whole Blood Flow Cytometry
- 1 April 2000
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 9 (4) , 808-812
- https://doi.org/10.1097/00000539-200004000-00007
Abstract
This experimental in vitro study demonstrates that heparin and its reversal agents affect platelet secretion and aggregation.Keywords
This publication has 13 references indexed in Scilit:
- Protamine Reversal of Heparin Affects Platelet Aggregation and Activated Clotting Time After Cardiopulmonary BypassAnesthesia & Analgesia, 1998
- Comparative Studies of Glycoprotein Ib in Heparin Coated and Nonheparin Coated Extracorporeal Circulation CircuitsAsaio Journal, 1998
- Aprotinin Inhibits Plasmin-Induced Platelet Activation During Cardiopulmonary BypassCirculation, 1997
- The Effects of Heparinase 1 and Protamine on Platelet ReactivityAnesthesiology, 1997
- MOLECULAR INSIGHTS INTO THE ANTICOAGULANT-INDUCED SPONTANEOUS ACTIVATION OF PLATELETS IN WHOLE BLOOD - VARIOUS ANTICOAGULANTS ARE NOT EQUALThrombosis Research, 1996
- Heparinase I (Neutralase) Reversal of Systemic AnticoagulationAnesthesiology, 1996
- Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operationsThe Annals of Thoracic Surgery, 1996
- Cardiopulmonary bypass leads to a preferential loss of activated plateletsA flow cytometric assay of platelet surface antigensEuropean Journal of Cardio-Thoracic Surgery, 1996
- Effect of heparin on platelet aggregationAmerican Journal of Hematology, 1984
- Heterogeneity of heparin lots associated with thrombocytopenia and thromboembolismThe American Journal of Medicine, 1984